Ionis Pharmaceuticals’ (IONS) “Buy” Rating Reaffirmed at Guggenheim
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Guggenheim in a report released on Thursday,Benzinga reports. Other equities research analysts have also issued reports about the stock. Redburn Atlantic initiated coverage on shares of Ionis Pharmaceuticals in a report on Monday, March 31st. They issued a […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Guggenheim in a report released on Thursday,Benzinga reports. Other equities research analysts have also issued reports about the stock. Redburn Atlantic initiated coverage on shares of Ionis Pharmaceuticals in a report on Monday, March 31st. They issued a […]
